J. Bernhard - Concepedia

Author

J. Bernhard

Swiss Group For Clinical Cancer Research

Also Known As

J Bernhard, J. Bernhard, J.C. Bernhard, Juerg Bernhard, Wegmayrc Bernhard, Jäger

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Swiss Group For Clinical Cancer Research University Hospital of Bern Kantonsspital St. Gallen International Breast Cancer Study Group Kantonsspital Graubünden

About

J. Bernhard is an author at Swiss Group For Clinical Cancer Research specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	931
2	Health Sciences	3	3	76
3	Public Health	3	3	141
4	Social Sciences	1	1	42
5	Behavioral Sciences	1	1	42

J. Bernhard

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Walter Weder, Rolf A. Stahel, J. Bernhard, Annals of Oncology Surgical OncologyMalignant Pleural MesotheliomaMedicinePleural DiseaseNeo-adjuvant Chemotherapy	2007	318
Meeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related Outcomes Richard Brown, Phyllis Butow, Maureen Wilson-Genderson, Journal of Clinical Oncology	2012	147
Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy J. Bernhard, Christoph Hürny, Rudolf Maibach, Annals of Oncology Quality Of LifeSurgical OncologyRadical ResectionColorectal SurgeryMedicine	1999	121
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity Markus Borner, J. Bernhard, Damien Dietrich, Annals of Oncology Gastrointestinal OncologyMedicinePharmacologyColorectal CancerMetastatic Colorectal Cancer	2005	102
On the receiving end IV: Validation of quality of life indicators Phyllis Butow, Alan S. Coates, S. Dunn, Annals of Oncology Life IndicatorsFamily MedicineQuality Of LifeLife SatisfactionLife Assessment	1991	76
Gemcitabine (G) plus capecitabine (C) versus G alone in locally advanced or metastatic pancreatic cancer. A randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG) R. Herrmann, G. Bodoky, Thomas Ruhstaller, Journal of Clinical Oncology Swiss GroupPancreatic CancerGastrointestinal OncologyMedicineLba4010 Background	2005	69
Acromioclavicular joint cyst: nine cases of a pseudotumor of the shoulder Dechen W. Tshering Vogel, Lynne S. Steinbach, R. Hertel, Skeletal Radiology Rotator CuffShoulder GirdleShoulder SurgeryAcromioclavicular Joint Cyst	2005	68
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma R. Morant, J. Bernhard, Rudolf Maibach, Annals of Oncology UrologyOncologyPhase Ii TrialGenitourinary CancerMedicine	2000	47
Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial Nicola Fazio, Roberto Biffi, Rudolf Maibach, Annals of Oncology Surgical Oncology10-Year Follow-upGastrointestinal OncologyMedicinePhase Iii Trial	2015	47
Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11–93 Beat Thürlimann, K.N. Price, M. Castiglione, The Breast	2001	46

Page 1